Home › Stargardt Disease › Oregon › Portland
Stargardt Disease clinical trials in Portland, OR
4 studies for Stargardt Disease are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
RecruitingObservational study
- Casey Eye Institute - Oregon Health & Science University, Portland
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
RecruitingPhase 1/2
- Casey Eye Institute OHSU, Portland
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
RecruitingObservational study
- Oregon Health & Science University, Portland
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
RecruitingPhase 1/2
- Oregon Health & Science University, Portland
Stargardt Disease trials in other cities
- Dallas, TX9 studies
- Boston, MA5 studies
- Phoenix, AZ4 studies
- Houston, TX4 studies
- Miami, FL4 studies
- Cincinnati, OH4 studies
- Gainesville, FL4 studies
- Ann Arbor, MI4 studies
- Aurora, CO3 studies
- Baltimore, MD3 studies
- Pittsburgh, PA3 studies
Other studies in Portland
- Non-Small Cell Lung Cancer45 studies
- Cancer (all types)35 studies
- Prostate Cancer33 studies
- Breast Cancer32 studies
- Metastatic Cancer30 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
- Acute Myeloid Leukemia25 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.